The lack of changes in HSP levels after the administration of IMI alone that we have shown in our study allows us to ensure that the results we present are specifically related to the mechanisms of depression and the effectiveness of antidepressant treatment generated by CMS molecular changes. The gene discussed is HSP90B2P; the disease is depressive symptom measurement.